Biosafety & IBC Compliance Analyst

Chemtrade; United States; Remote; USD 59,000 - 92,000; Full time

Job summary

WCG’s Biosafety Analyst role supports scientific review for institutions to enable IBC approval of human gene transfer studies. You will work with IBC Specialists to prepare documents and coordinate communications with hospitals, clinics, and laboratories.

The position emphasizes ensuring NIH Guidelines compliance, biosafety program improvements, and effective training for clients on IBC processes and NIH regulations.

Qualifications

• Experience in clinical, pharmaceutical, or biomedical research settings (minimum 2 years).
• Ability to analyze training, facilities, and operations for IBC review.
• Knowledge of NIH Guidelines for Research with Recombinant and Synthetic Nucleic Acids.
• Excellent communication and documentation skills.

Responsibilities

• Analyze the training, facilities, and operations of institutions, and provide guidance to personnel and staff members to prepare for IBC review of human gene transfer studies.
• Provide education and analysis to institutions regarding compliance with NIH Guidelines and affiliated regulations.
• Assist institutions with identifying areas in their biosafety programs to improve compliance with regulations and standards.
• Ensure all assigned studies are reviewed by the IBC prior to approval expiration.
• Identify training opportunities for new clients and participate in orientations and training on IBCs and NIH Guidelines.

Skills

IBC review support

Biomedical terminology

Regulatory compliance

NIH Guidelines

Education

Bachelor's degree in life sciences

Job description

WCG’s Biosafety Analyst role supports scientific review for institutions to enable IBC approval of human gene transfer studies. You will work with IBC Specialists to prepare documents and coordinate communications with hospitals, clinics, and laboratories.

The position emphasizes ensuring NIH Guidelines compliance, biosafety program improvements, and effective training for clients on IBC processes and NIH regulations.